A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Name: A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
License: Public Domain

GI Innovation, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced solid tumor, metastatic solid tumor, soft tissue sarcoma (sts), platinum-resistant ovarian cancer (proc), hepatocellular carcinoma (hcc), colorectal cancer (crc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 162475
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.